HEADER CELL CYCLE 18-FEB-22 7YYX TITLE MOLECULAR SNAPSHOTS OF DRUG RELEASE FROM TUBULIN: 100 NANOSECONDS TITLE 2 AFTER PHOTOACTIVATION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUBULIN ALPHA-1B CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALPHA-TUBULIN UBIQUITOUS,TUBULIN K-ALPHA-1,TUBULIN ALPHA- COMPND 5 UBIQUITOUS CHAIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: TUBULIN BETA-2B CHAIN; COMPND 8 CHAIN: B; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) D1; COMPND 11 CHAIN: F; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 7 ORGANISM_COMMON: CATTLE; SOURCE 8 ORGANISM_TAXID: 9913; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS TIME-RESOLVED SERIAL CRYSTALLOGRAPHY, TUBULIN DYNAMICS, AZOBENZENE KEYWDS 2 DYNAMICS, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR M.WRANIK,T.WEINERT,J.STANDFUSS REVDAT 4 27-SEP-23 7YYX 1 COMPND HET HETNAM HETSYN REVDAT 4 2 1 FORMUL ATOM REVDAT 3 13-SEP-23 7YYX 1 COMPND FORMUL REVDAT 2 08-MAR-23 7YYX 1 JRNL REVDAT 1 22-FEB-23 7YYX 0 JRNL AUTH M.WRANIK,T.WEINERT,C.SLAVOV,T.MASINI,A.FURRER,N.GAILLARD, JRNL AUTH 2 D.GIOIA,M.FERRAROTTI,D.JAMES,H.GLOVER,M.CARRILLO,D.KEKILLI, JRNL AUTH 3 R.STIPP,P.SKOPINTSEV,S.BRUNLE,T.MUHLETHALER,J.BEALE,D.GASHI, JRNL AUTH 4 K.NASS,D.OZEROV,P.J.M.JOHNSON,C.CIRELLI,C.BACELLAR,M.BRAUN, JRNL AUTH 5 M.WANG,F.DWORKOWSKI,C.MILNE,A.CAVALLI,J.WACHTVEITL, JRNL AUTH 6 M.O.STEINMETZ,J.STANDFUSS JRNL TITL WATCHING THE RELEASE OF A PHOTOPHARMACOLOGICAL DRUG FROM JRNL TITL 2 TUBULIN USING TIME-RESOLVED SERIAL CRYSTALLOGRAPHY. JRNL REF NAT COMMUN V. 14 903 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36807348 JRNL DOI 10.1038/S41467-023-36481-5 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.WRANIK,T.WEINERT,C.SLAVOV,T.MASINI,A.FURRER,N.GAILLARD, REMARK 1 AUTH 2 D.GIOIA,M.FERRAROTTI,D.JAMES,H.GLOVER,M.CARRILLO,D.KEKILLI, REMARK 1 AUTH 3 R.STIPP,P.SKOPINTSEV,S.BRUNLE,T.MUHLETHALER,J.BEALE,D.GASHI, REMARK 1 AUTH 4 K.NASS,D.OZEROV,P.JOHNSON,C.CIRELLI,C.BACELLAR,M.BRAUN, REMARK 1 AUTH 5 M.WANG,F.DWORKOWSKI,C.MILNE,A.CAVALLI,J.WACHTVEITL, REMARK 1 AUTH 6 M.STEINMETZ,J.STANDFUSS REMARK 1 TITL RELEASE OF A PHOTOPHARMACOLOGICAL DRUG FROM ITS PROTEIN REMARK 1 TITL 2 TARGET CAPTURED BY TIME-RESOLVED SERIAL CRYSTALLOGRAPHY REMARK 1 REF RES SQ 2022 REMARK 1 REFN ESSN 2693-5015 REMARK 1 DOI 10.21203/RS.3.RS-1964458/V1 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 52461 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.313 REMARK 3 R VALUE (WORKING SET) : 0.311 REMARK 3 FREE R VALUE : 0.355 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.460 REMARK 3 FREE R VALUE TEST SET COUNT : 1815 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 9.4900 - 4.9400 0.96 4054 196 0.2822 0.3347 REMARK 3 2 4.9400 - 4.0200 0.97 4194 97 0.2597 0.2637 REMARK 3 3 4.0200 - 3.5400 0.97 4064 189 0.2852 0.3103 REMARK 3 4 3.5400 - 3.2300 0.97 4129 94 0.3017 0.3243 REMARK 3 5 3.2300 - 3.0100 0.96 3999 186 0.3185 0.3683 REMARK 3 6 3.0100 - 2.8300 0.95 4070 95 0.3303 0.4043 REMARK 3 7 2.8300 - 2.6900 0.94 3907 187 0.3413 0.4285 REMARK 3 8 2.6900 - 2.5800 0.88 3755 85 0.3650 0.4126 REMARK 3 9 2.5800 - 2.4800 0.92 3826 177 0.3512 0.3866 REMARK 3 10 2.4800 - 2.4000 0.84 3563 78 0.3830 0.4491 REMARK 3 11 2.4000 - 2.3200 0.90 3750 175 0.3859 0.4826 REMARK 3 12 2.3200 - 2.2600 0.88 3728 100 0.3941 0.4723 REMARK 3 13 2.2600 - 2.2000 0.87 3607 156 0.3926 0.4378 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 41.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7YYX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292121133. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-20 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : ESA REMARK 200 X-RAY GENERATOR MODEL : SWISSFEL ARAMIS BEAMLINE ESA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI JUNGFRAU 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL 0.9.1 REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL 0.9.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 122150 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 11.090 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 314.1 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.620 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5NQT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.1M BIS/TRIS REMARK 280 -METHANE PH=5.5, 21% PEG 3000 (M/V), VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.29000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 37220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -53.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 438 REMARK 465 SER A 439 REMARK 465 VAL A 440 REMARK 465 GLU A 441 REMARK 465 GLY A 442 REMARK 465 GLU A 443 REMARK 465 GLY A 444 REMARK 465 GLU A 445 REMARK 465 GLU A 446 REMARK 465 GLU A 447 REMARK 465 GLY A 448 REMARK 465 GLU A 449 REMARK 465 GLU A 450 REMARK 465 TYR A 451 REMARK 465 GLN B 279 REMARK 465 GLN B 280 REMARK 465 TYR B 281 REMARK 465 ARG B 282 REMARK 465 ALA B 283 REMARK 465 GLU B 432 REMARK 465 GLN B 433 REMARK 465 GLY B 434 REMARK 465 GLU B 435 REMARK 465 PHE B 436 REMARK 465 GLU B 437 REMARK 465 GLU B 438 REMARK 465 GLU B 439 REMARK 465 GLU B 440 REMARK 465 GLY B 441 REMARK 465 GLU B 442 REMARK 465 ASP B 443 REMARK 465 GLU B 444 REMARK 465 ALA B 445 REMARK 465 MET F 1 REMARK 465 ARG F 2 REMARK 465 GLY F 3 REMARK 465 SER F 4 REMARK 465 HIS F 5 REMARK 465 HIS F 6 REMARK 465 HIS F 7 REMARK 465 HIS F 8 REMARK 465 HIS F 9 REMARK 465 HIS F 10 REMARK 465 GLY F 11 REMARK 465 SER F 12 REMARK 465 LEU F 168 REMARK 465 ASN F 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 40 CG CD CE NZ REMARK 470 LYS A 163 CG CD CE NZ REMARK 470 GLU A 220 CG CD OE1 OE2 REMARK 470 ASN B 48 CG OD1 ND2 REMARK 470 THR B 55 OG1 CG2 REMARK 470 ASN B 57 CG OD1 ND2 REMARK 470 GLN B 94 CG CD OE1 NE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 THR A 194 CA CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 83 37.49 -87.92 REMARK 500 THR A 109 -78.61 -90.03 REMARK 500 HIS A 266 41.88 -106.40 REMARK 500 TYR A 282 40.84 -96.95 REMARK 500 ILE A 335 46.83 -88.68 REMARK 500 THR A 337 -36.02 -135.23 REMARK 500 THR A 349 21.50 -75.47 REMARK 500 PHE A 404 -0.31 67.19 REMARK 500 ARG B 2 -74.52 -150.34 REMARK 500 PHE B 81 35.34 -91.46 REMARK 500 THR B 107 -80.27 -118.80 REMARK 500 CYS B 129 89.63 -151.12 REMARK 500 ASP B 177 48.62 -90.78 REMARK 500 PRO B 243 -85.24 -60.88 REMARK 500 ARG B 276 45.03 -86.82 REMARK 500 HIS F 69 41.66 -143.58 REMARK 500 GLN F 166 49.43 -97.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 668 DISTANCE = 5.87 ANGSTROMS REMARK 525 HOH F 243 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH F 244 DISTANCE = 6.40 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 503 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 39 OD1 REMARK 620 2 ASP A 39 OD2 52.4 REMARK 620 3 THR A 41 O 75.1 75.4 REMARK 620 4 THR A 41 OG1 70.7 117.3 65.8 REMARK 620 5 GLY A 44 O 149.3 155.8 98.1 79.2 REMARK 620 6 GLU A 55 OE1 123.4 72.0 82.4 141.2 84.2 REMARK 620 7 GLU A 55 OE2 122.5 83.1 132.1 157.8 84.6 50.2 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 502 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GTP A 501 O1G REMARK 620 2 GTP A 501 O2B 79.3 REMARK 620 3 HOH A 612 O 151.8 82.4 REMARK 620 4 HOH A 616 O 99.1 94.1 103.5 REMARK 620 5 HOH A 639 O 94.8 157.6 94.0 108.2 REMARK 620 6 HOH A 648 O 77.5 68.6 75.9 162.7 89.0 REMARK 620 N 1 2 3 4 5 DBREF 7YYX A 1 451 UNP P81947 TBA1B_BOVIN 1 451 DBREF 7YYX B 1 445 UNP Q6B856 TBB2B_BOVIN 1 445 DBREF 7YYX F 1 169 PDB 7YYX 7YYX 1 169 SEQRES 1 A 451 MET ARG GLU CYS ILE SER ILE HIS VAL GLY GLN ALA GLY SEQRES 2 A 451 VAL GLN ILE GLY ASN ALA CYS TRP GLU LEU TYR CYS LEU SEQRES 3 A 451 GLU HIS GLY ILE GLN PRO ASP GLY GLN MET PRO SER ASP SEQRES 4 A 451 LYS THR ILE GLY GLY GLY ASP ASP SER PHE ASN THR PHE SEQRES 5 A 451 PHE SER GLU THR GLY ALA GLY LYS HIS VAL PRO ARG ALA SEQRES 6 A 451 VAL PHE VAL ASP LEU GLU PRO THR VAL ILE ASP GLU VAL SEQRES 7 A 451 ARG THR GLY THR TYR ARG GLN LEU PHE HIS PRO GLU GLN SEQRES 8 A 451 LEU ILE THR GLY LYS GLU ASP ALA ALA ASN ASN TYR ALA SEQRES 9 A 451 ARG GLY HIS TYR THR ILE GLY LYS GLU ILE ILE ASP LEU SEQRES 10 A 451 VAL LEU ASP ARG ILE ARG LYS LEU ALA ASP GLN CYS THR SEQRES 11 A 451 GLY LEU GLN GLY PHE LEU VAL PHE HIS SER PHE GLY GLY SEQRES 12 A 451 GLY THR GLY SER GLY PHE THR SER LEU LEU MET GLU ARG SEQRES 13 A 451 LEU SER VAL ASP TYR GLY LYS LYS SER LYS LEU GLU PHE SEQRES 14 A 451 SER ILE TYR PRO ALA PRO GLN VAL SER THR ALA VAL VAL SEQRES 15 A 451 GLU PRO TYR ASN SER ILE LEU THR THR HIS THR THR LEU SEQRES 16 A 451 GLU HIS SER ASP CYS ALA PHE MET VAL ASP ASN GLU ALA SEQRES 17 A 451 ILE TYR ASP ILE CYS ARG ARG ASN LEU ASP ILE GLU ARG SEQRES 18 A 451 PRO THR TYR THR ASN LEU ASN ARG LEU ILE SER GLN ILE SEQRES 19 A 451 VAL SER SER ILE THR ALA SER LEU ARG PHE ASP GLY ALA SEQRES 20 A 451 LEU ASN VAL ASP LEU THR GLU PHE GLN THR ASN LEU VAL SEQRES 21 A 451 PRO TYR PRO ARG ILE HIS PHE PRO LEU ALA THR TYR ALA SEQRES 22 A 451 PRO VAL ILE SER ALA GLU LYS ALA TYR HIS GLU GLN LEU SEQRES 23 A 451 SER VAL ALA GLU ILE THR ASN ALA CYS PHE GLU PRO ALA SEQRES 24 A 451 ASN GLN MET VAL LYS CYS ASP PRO ARG HIS GLY LYS TYR SEQRES 25 A 451 MET ALA CYS CYS LEU LEU TYR ARG GLY ASP VAL VAL PRO SEQRES 26 A 451 LYS ASP VAL ASN ALA ALA ILE ALA THR ILE LYS THR LYS SEQRES 27 A 451 ARG SER ILE GLN PHE VAL ASP TRP CYS PRO THR GLY PHE SEQRES 28 A 451 LYS VAL GLY ILE ASN TYR GLN PRO PRO THR VAL VAL PRO SEQRES 29 A 451 GLY GLY ASP LEU ALA LYS VAL GLN ARG ALA VAL CYS MET SEQRES 30 A 451 LEU SER ASN THR THR ALA ILE ALA GLU ALA TRP ALA ARG SEQRES 31 A 451 LEU ASP HIS LYS PHE ASP LEU MET TYR ALA LYS ARG ALA SEQRES 32 A 451 PHE VAL HIS TRP TYR VAL GLY GLU GLY MET GLU GLU GLY SEQRES 33 A 451 GLU PHE SER GLU ALA ARG GLU ASP MET ALA ALA LEU GLU SEQRES 34 A 451 LYS ASP TYR GLU GLU VAL GLY VAL ASP SER VAL GLU GLY SEQRES 35 A 451 GLU GLY GLU GLU GLU GLY GLU GLU TYR SEQRES 1 B 445 MET ARG GLU ILE VAL HIS ILE GLN ALA GLY GLN CYS GLY SEQRES 2 B 445 ASN GLN ILE GLY ALA LYS PHE TRP GLU VAL ILE SER ASP SEQRES 3 B 445 GLU HIS GLY ILE ASP PRO THR GLY SER TYR HIS GLY ASP SEQRES 4 B 445 SER ASP LEU GLN LEU GLU ARG ILE ASN VAL TYR TYR ASN SEQRES 5 B 445 GLU ALA THR GLY ASN LYS TYR VAL PRO ARG ALA ILE LEU SEQRES 6 B 445 VAL ASP LEU GLU PRO GLY THR MET ASP SER VAL ARG SER SEQRES 7 B 445 GLY PRO PHE GLY GLN ILE PHE ARG PRO ASP ASN PHE VAL SEQRES 8 B 445 PHE GLY GLN SER GLY ALA GLY ASN ASN TRP ALA LYS GLY SEQRES 9 B 445 HIS TYR THR GLU GLY ALA GLU LEU VAL ASP SER VAL LEU SEQRES 10 B 445 ASP VAL VAL ARG LYS GLU SER GLU SER CYS ASP CYS LEU SEQRES 11 B 445 GLN GLY PHE GLN LEU THR HIS SER LEU GLY GLY GLY THR SEQRES 12 B 445 GLY SER GLY MET GLY THR LEU LEU ILE SER LYS ILE ARG SEQRES 13 B 445 GLU GLU TYR PRO ASP ARG ILE MET ASN THR PHE SER VAL SEQRES 14 B 445 MET PRO SER PRO LYS VAL SER ASP THR VAL VAL GLU PRO SEQRES 15 B 445 TYR ASN ALA THR LEU SER VAL HIS GLN LEU VAL GLU ASN SEQRES 16 B 445 THR ASP GLU THR TYR CYS ILE ASP ASN GLU ALA LEU TYR SEQRES 17 B 445 ASP ILE CYS PHE ARG THR LEU LYS LEU THR THR PRO THR SEQRES 18 B 445 TYR GLY ASP LEU ASN HIS LEU VAL SER ALA THR MET SER SEQRES 19 B 445 GLY VAL THR THR CYS LEU ARG PHE PRO GLY GLN LEU ASN SEQRES 20 B 445 ALA ASP LEU ARG LYS LEU ALA VAL ASN MET VAL PRO PHE SEQRES 21 B 445 PRO ARG LEU HIS PHE PHE MET PRO GLY PHE ALA PRO LEU SEQRES 22 B 445 THR SER ARG GLY SER GLN GLN TYR ARG ALA LEU THR VAL SEQRES 23 B 445 PRO GLU LEU THR GLN GLN MET PHE ASP SER LYS ASN MET SEQRES 24 B 445 MET ALA ALA CYS ASP PRO ARG HIS GLY ARG TYR LEU THR SEQRES 25 B 445 VAL ALA ALA ILE PHE ARG GLY ARG MET SER MET LYS GLU SEQRES 26 B 445 VAL ASP GLU GLN MET LEU ASN VAL GLN ASN LYS ASN SER SEQRES 27 B 445 SER TYR PHE VAL GLU TRP ILE PRO ASN ASN VAL LYS THR SEQRES 28 B 445 ALA VAL CYS ASP ILE PRO PRO ARG GLY LEU LYS MET SER SEQRES 29 B 445 ALA THR PHE ILE GLY ASN SER THR ALA ILE GLN GLU LEU SEQRES 30 B 445 PHE LYS ARG ILE SER GLU GLN PHE THR ALA MET PHE ARG SEQRES 31 B 445 ARG LYS ALA PHE LEU HIS TRP TYR THR GLY GLU GLY MET SEQRES 32 B 445 ASP GLU MET GLU PHE THR GLU ALA GLU SER ASN MET ASN SEQRES 33 B 445 ASP LEU VAL SER GLU TYR GLN GLN TYR GLN ASP ALA THR SEQRES 34 B 445 ALA ASP GLU GLN GLY GLU PHE GLU GLU GLU GLU GLY GLU SEQRES 35 B 445 ASP GLU ALA SEQRES 1 F 169 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER ASP SEQRES 2 F 169 LEU GLY LYS LYS LEU LEU GLU ALA ALA ARG ALA GLY GLN SEQRES 3 F 169 ASP ASP GLU VAL ARG ILE LEU MET ALA ASN GLY ALA ASP SEQRES 4 F 169 VAL ASN ALA THR ASP ALA SER GLY LEU THR PRO LEU HIS SEQRES 5 F 169 LEU ALA ALA THR TYR GLY HIS LEU GLU ILE VAL GLU VAL SEQRES 6 F 169 LEU LEU LYS HIS GLY ALA ASP VAL ASN ALA ILE ASP ILE SEQRES 7 F 169 MET GLY SER THR PRO LEU HIS LEU ALA ALA LEU ILE GLY SEQRES 8 F 169 HIS LEU GLU ILE VAL GLU VAL LEU LEU LYS HIS GLY ALA SEQRES 9 F 169 ASP VAL ASN ALA VAL ASP THR TRP GLY ASP THR PRO LEU SEQRES 10 F 169 HIS LEU ALA ALA ILE MET GLY HIS LEU GLU ILE VAL GLU SEQRES 11 F 169 VAL LEU LEU LYS HIS GLY ALA ASP VAL ASN ALA GLN ASP SEQRES 12 F 169 LYS PHE GLY LYS THR ALA PHE ASP ILE SER ILE ASP ASN SEQRES 13 F 169 GLY ASN GLU ASP LEU ALA GLU ILE LEU GLN LYS LEU ASN HET GTP A 501 32 HET MG A 502 1 HET CA A 503 1 HET GDP B 501 28 HET VYT B 502 23 HETNAM GTP GUANOSINE-5'-TRIPHOSPHATE HETNAM MG MAGNESIUM ION HETNAM CA CALCIUM ION HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM VYT AZO-COMBRETASTATIN A4 (TRANS) HETSYN VYT 2-METHOXY-5-[(E)-(3,4,5-TRIMETHOXYPHENYL) HETSYN 2 VYT DIAZENYL]PHENOL FORMUL 4 GTP C10 H16 N5 O14 P3 FORMUL 5 MG MG 2+ FORMUL 6 CA CA 2+ FORMUL 7 GDP C10 H15 N5 O11 P2 FORMUL 8 VYT C16 H18 N2 O5 FORMUL 9 HOH *211(H2 O) HELIX 1 AA1 GLY A 10 GLY A 29 1 20 HELIX 2 AA2 ASP A 47 THR A 51 5 5 HELIX 3 AA3 PRO A 72 GLY A 81 1 10 HELIX 4 AA4 THR A 82 LEU A 86 5 5 HELIX 5 AA5 HIS A 88 GLU A 90 5 3 HELIX 6 AA6 ASN A 102 TYR A 108 1 7 HELIX 7 AA7 THR A 109 GLU A 113 5 5 HELIX 8 AA8 ILE A 114 GLN A 128 1 15 HELIX 9 AA9 GLY A 143 TYR A 161 1 19 HELIX 10 AB1 ALA A 174 SER A 178 5 5 HELIX 11 AB2 VAL A 182 LEU A 195 1 14 HELIX 12 AB3 ASN A 206 ASN A 216 1 11 HELIX 13 AB4 THR A 223 PHE A 244 1 22 HELIX 14 AB5 ASP A 251 VAL A 260 1 10 HELIX 15 AB6 SER A 287 CYS A 295 1 9 HELIX 16 AB7 PHE A 296 GLN A 301 5 6 HELIX 17 AB8 ASP A 306 GLY A 310 5 5 HELIX 18 AB9 VAL A 324 ILE A 335 1 12 HELIX 19 AC1 ILE A 384 ALA A 400 1 17 HELIX 20 AC2 PHE A 404 GLY A 410 1 7 HELIX 21 AC3 GLU A 415 GLY A 436 1 22 HELIX 22 AC4 GLY B 10 GLY B 29 1 20 HELIX 23 AC5 SER B 40 LEU B 44 5 5 HELIX 24 AC6 ARG B 46 VAL B 49 5 4 HELIX 25 AC7 GLU B 69 SER B 78 1 10 HELIX 26 AC8 ARG B 86 ASP B 88 5 3 HELIX 27 AC9 ASN B 100 TYR B 106 1 7 HELIX 28 AD1 LEU B 112 SER B 126 1 15 HELIX 29 AD2 GLY B 142 TYR B 159 1 18 HELIX 30 AD3 VAL B 180 THR B 196 1 17 HELIX 31 AD4 ASN B 204 THR B 214 1 11 HELIX 32 AD5 THR B 221 THR B 237 1 17 HELIX 33 AD6 THR B 237 PHE B 242 1 6 HELIX 34 AD7 ASP B 249 VAL B 258 1 10 HELIX 35 AD8 THR B 285 PHE B 294 1 10 HELIX 36 AD9 ASP B 304 GLY B 308 5 5 HELIX 37 AE1 SER B 322 ASN B 337 1 16 HELIX 38 AE2 SER B 338 PHE B 341 5 4 HELIX 39 AE3 ILE B 374 ARG B 391 1 18 HELIX 40 AE4 LEU B 395 GLY B 400 1 6 HELIX 41 AE5 GLU B 405 ASP B 427 1 23 HELIX 42 AE6 LEU F 14 GLY F 25 1 12 HELIX 43 AE7 GLN F 26 ASN F 36 1 11 HELIX 44 AE8 THR F 49 TYR F 57 1 9 HELIX 45 AE9 HIS F 59 LYS F 68 1 10 HELIX 46 AF1 THR F 82 GLY F 91 1 10 HELIX 47 AF2 HIS F 92 HIS F 102 1 11 HELIX 48 AF3 THR F 115 MET F 123 1 9 HELIX 49 AF4 HIS F 125 LYS F 134 1 10 HELIX 50 AF5 THR F 148 ASN F 156 1 9 HELIX 51 AF6 ASN F 158 GLN F 166 1 9 SHEET 1 AA1 6 LEU A 92 THR A 94 0 SHEET 2 AA1 6 ALA A 65 ASP A 69 1 N PHE A 67 O ILE A 93 SHEET 3 AA1 6 CYS A 4 VAL A 9 1 N HIS A 8 O VAL A 68 SHEET 4 AA1 6 GLY A 134 SER A 140 1 O LEU A 136 N ILE A 7 SHEET 5 AA1 6 SER A 165 TYR A 172 1 O LEU A 167 N PHE A 135 SHEET 6 AA1 6 CYS A 200 ASP A 205 1 O PHE A 202 N GLU A 168 SHEET 1 AA2 2 PHE A 53 GLU A 55 0 SHEET 2 AA2 2 HIS A 61 PRO A 63 -1 O VAL A 62 N SER A 54 SHEET 1 AA3 4 LEU A 269 ALA A 273 0 SHEET 2 AA3 4 ARG A 373 THR A 381 -1 O SER A 379 N LEU A 269 SHEET 3 AA3 4 TYR A 312 GLY A 321 -1 N CYS A 316 O LEU A 378 SHEET 4 AA3 4 LYS A 352 ASN A 356 1 O LYS A 352 N LEU A 317 SHEET 1 AA410 PHE B 90 PHE B 92 0 SHEET 2 AA410 ALA B 63 ASP B 67 1 N LEU B 65 O VAL B 91 SHEET 3 AA410 ILE B 4 ALA B 9 1 N GLN B 8 O VAL B 66 SHEET 4 AA410 GLY B 132 SER B 138 1 O GLN B 134 N ILE B 7 SHEET 5 AA410 ILE B 163 MET B 170 1 O PHE B 167 N LEU B 135 SHEET 6 AA410 GLU B 198 ASP B 203 1 O ILE B 202 N MET B 170 SHEET 7 AA410 PHE B 265 ALA B 271 1 O PHE B 266 N THR B 199 SHEET 8 AA410 MET B 363 SER B 371 -1 O GLY B 369 N MET B 267 SHEET 9 AA410 TYR B 310 GLY B 319 -1 N LEU B 311 O ASN B 370 SHEET 10 AA410 VAL B 349 CYS B 354 1 O ALA B 352 N PHE B 317 SHEET 1 AA5 2 TYR B 51 ALA B 54 0 SHEET 2 AA5 2 LYS B 58 PRO B 61 -1 O LYS B 58 N ALA B 54 LINK OD1 ASP A 39 CA CA A 503 1555 1555 2.57 LINK OD2 ASP A 39 CA CA A 503 1555 1555 2.39 LINK O THR A 41 CA CA A 503 1555 1555 2.43 LINK OG1 THR A 41 CA CA A 503 1555 1555 2.66 LINK O GLY A 44 CA CA A 503 1555 1555 2.37 LINK OE1 GLU A 55 CA CA A 503 1555 1555 2.73 LINK OE2 GLU A 55 CA CA A 503 1555 1555 2.40 LINK O1G GTP A 501 MG MG A 502 1555 1555 2.16 LINK O2B GTP A 501 MG MG A 502 1555 1555 2.37 LINK MG MG A 502 O HOH A 612 1555 1555 2.41 LINK MG MG A 502 O HOH A 616 1555 1555 1.99 LINK MG MG A 502 O HOH A 639 1555 1555 2.13 LINK MG MG A 502 O HOH A 648 1555 1555 2.47 CISPEP 1 ALA A 273 PRO A 274 0 -2.02 CISPEP 2 ALA B 271 PRO B 272 0 0.77 CRYST1 74.530 92.580 83.990 90.00 96.71 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013417 0.000000 0.001579 0.00000 SCALE2 0.000000 0.010801 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011988 0.00000